From decision to shared-decision: Introducing patients' preferences into clinical decision analysis

Artificial Intelligence in Medicine

Volumn 65, Issue 1, 2015, Pages 19-28

  Sacchi, Lucia ^a   Rubrichi, Stefania ^a   Rognoni, Carla ^a,b   Panzarasa, Silvia ^a   Parimbelli, Enea ^a   Mazzanti, Andrea ^c   Napolitano, Carlo ^c   Priori, Silvia G ^a,c   Quaglini, Silvana ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b BOCCONI UNIVERSITY   (Italy)

^c IRCCS   (Italy)

Author keywords

Atrial fibrillation; Decision trees; Patient preferences; Shared decision making; Utility coefficients

Indexed keywords

DECISION TREES; DISEASES; MEDICAL APPLICATIONS; PATIENT REHABILITATION;

ATRIAL FIBRILLATION; CLINICAL DECISION PROCESS; CLINICAL EVALUATION; CLINICAL PRACTICE GUIDELINES; EVIDENCE-BASED MEDICINE; PATIENT PREFERENCES; SHARED DECISION MAKINGS; UTILITY COEFFICIENTS;

DECISION MAKING;

ARTICLE; ATRIAL FIBRILLATION; CLINICAL DECISION MAKING; CONCEPTUAL FRAMEWORK; COST UTILITY ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; ITALY; PATIENT DECISION MAKING; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; THROMBOEMBOLISM; COMPLICATION; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; PATIENT PARTICIPATION; PROCEDURES;

ANTICOAGULANT AGENT;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CLINICAL DECISION-MAKING; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT PARTICIPATION; PATIENT PREFERENCE; THROMBOEMBOLISM;

EID: 84941962976     PISSN: 09333657     EISSN: 18732860     Source Type: Journal    
DOI: 10.1016/j.artmed.2014.10.004     Document Type: Article

References (37)

1. Llewellyn-Thomas H.A., Crump T. Decision support for patients: values clarification and preference elicitation. Med Care Res Rev 2013, 70(Suppl. 1):50S-79S.
2. Hack T.F., Degner L.F., Watson P., Sinha L. Do patients benefit from participating in medical decision making?. Longitudinal follow-up of women with breast cancer. Psychooncology 2006, 15(1):9-19.
3. Chewning B., Bylund C.L., Shah B., Arora N.H., Gueguen J.A., Makoul G. Patient preferences for shared decisions: a systematic review. Patient Educ Couns 2012, 86(1):9-18.
4. Institute of Medicine Crossing the quality chasm: a new health system for the 21st century 2001, National Academy Press, Washington.
5. Weinstein M.C., Fineberg H.V. Clinical decision analysis 1980, Saunders, Philadelphia.
6. Politi M.C., Street R.L. The importance of communication in collaborative decision making: facilitating shared mind and the management of uncertainty. J Eval Clin Pract 2011, 17(4):579-584.
7. Charles C., Gafni A., Whelan T. Shared decision-making in the medical encounter: what does it mean?. Soc Sci Med 1997, 44:681-692.
8. Edwards A., Elwyn G. Inside the black box of shared decision making: distinguishing between the process of involvement and who makes the decision. Health Expect 2006, 9(4):307-320.
9. Makoul G., Clayman M.L. An integrative model of shared decision making in medical encounters. Patient Educ Couns 2006, 60(3):301-312.
10. Sacchi L., Rognoni C., Rubrichi S., Panzarasa S., Quaglini S. From decision to shared-decision: introducing patients' preferences in clinical decision analysis - a case study in thromboembolic risk prevention. Lecture notes in computer science (including subseries lecture notes in artificial intelligence and lecture notes in bioinformatics) 2013, Springer, Berlin, 7885 LNAI 1-10. N. Peek, R.M. Morales, M. Peleg (Eds.).
11. Soares M.O. Is the QALY blind, deaf and dumb to equity? NICE's considerations over equity. Br Med Bull 2012, 101:17-31.
12. Bell C.M., Chapman R.H., Stone P.W., Sandberg E.A., Neumann P.J. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses. Med Decis Mak 2001, 21(4):288-294.
13. CEA Registry website, (accessed 01.10.14). https://research.tufts-nemc.org/cear4/.
14. Bleichrodt H., Johannesson M. An experimental test of a theoretical foundation for rating-scale valuations. Med Decis Mak 1997, 17:208-216.
15. Torrance G.W., Thomas W.H., Sackett D.L. A utility maximization model for evaluation of health care programs. Health Serv Res 1972, 7:118-133.
16. Von Neumann J., Morgenstern O. Theory of games and economic behavior 1944, Princeton University Press, Princeton.
17. Gerzeli S., Tarricone R., Zolo P., Colangelo I., Busca M.R., Gandolfo C. The economic burden of stroke in Italy. The EcLIPSE Study: economic longitudinal incidence-based project for stroke evaluation. Neurol Sci 2005, 26(2):72-80.
18. Sonnenberg F.A., Beck J.R. Markov models in medical decision making: a practical guide. Med Decis Mak 1993, 13(4):322-338.
19. Friedberg M.W., Van Busum K., Wexler R., Bowen M., Schneider E.C. A demonstration of shared decision making in primary care highlights barriers to adoption and potential remedies. Health Aff 2013, 32(2):268-275.
20. American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011, 123(10):e269-e367.
21. Anderson J.L., Halperin J.L., Albert N.M., Bozkurt B., Brindis R.G., Curtis L.H., et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2013, 127(18):1916-1926.
22. Rognoni C., Marchetti M., Quaglini S., Liberato N.L. Apixaban, Dabigatran, and Rivaroxaban versus Warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis. Clin Drug Investig 2014, 34(1):9-17.
23. Connolly S.J., Ezekowitz M.D., Yusuf S., Eikelboom J., Oldgren J., Parekh A., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139-1151.
24. Granger C.B., Alexander J.H., McMurray J.J., Lopes R.D., Hylek E.M., Hanna M., et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-992.
25. Patel M.R., Mahaffey K.W., Garg J., Pan G., Singer D.E., Hacke W., et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011, 365:883-891.
26. Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007, 146:857-867.
27. Hart R.G., Benavente O., McBride R., Pearce L.A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999, 131:492-501.
28. Lip G.Y.H. Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. J Thromb Haemost 2011, 9(Suppl. 1):344-351.
29. Berg J., Lindgren P., Nieuwlaat R., Bouin O., Crijns H. Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Qual Life Res 2010, 19:381-390.
30. Politi M.C., Lewis C.L., Frosch D.L. Supporting shared decisions when clinical evidence is low. Med Care Res Rev 2013, 70(1 Suppl.):113S-128S.
31. Stacey D., Murray M.A., Légaré F., Sandy D., Menard P., O'Connor A. Decision coaching to support shared decision making: a framework, evidence, and implications for nursing practice, education, and policy. Worldviews Evid Based Nurs 2008, 5(1):25-35.
32. Epstein R.M., Peters E. Beyond information: exploring patients' preferences. JAMA 2009, 8:195-197.
33. Johnson E.J., Steffel M., Goldstein D.G. Making better decisions: from measuring to constructing preferences. Health Psychol 2005, 24(4 Suppl):S17-S22.
34. Guerrier M., Légaré F., Turcotte S., Labrecque M., Rivest L.P. Shared decision making does not influence physicians against clinical practice guidelines. PLOS ONE 2013, 8(4):e62537.
35. Gravel K., Légaré F., Graham I.D. Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals' perceptions. Implement Sci 2006, 9:1-16.
36. O'Reilly D., Holbrook A., Blackhouse G., Troyan S., Goeree R. Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records. J Am Med Inf Assoc 2012, 19(3):341-345.
37. Ofman J.J., Badamgarav E., Henning J.M., Knight K., Gano A.D., Levan R.K., et al. Does disease management improve clinical and economic outcomes in patients with chronic diseases?. A systematic review. Am J Med 2004, 117:182-192.